Posts by: Joana Carvalho

News

The costs of care for people with inflammatory bowel disease (IBD) living in the U.S. have steadily increased over the last five years, primarily due to the high price ... Read more

July 1, 2019July 1, 2019

Therapy Candidate IMU-838 Shows Strong Activity in Preclinical Models of UC, Immunic Announces

News

IMU-838, Immunic Therapeutics‘ lead therapy candidate for the treatment of ulcerative colitis (UC) and relapsing-remitting multiple sclerosis (RRMS), shows strong activity in cellular and animal models of disease, preclinical ... Read more

June 24, 2019June 24, 2019

Phase 2 Trials Begin Dosing Patients with SHR0302, Reistone’s Investigational JAK1 Inhibitor

News

The first patients with ulcerative colitis (UC) and Crohn’s disease (CD) have been dosed in two Phase 2 trials assessing the effects of SHR0302, Reistone Biopharma‘s investigational drug for ... Read more

June 14, 2019June 14, 2019

IBD Mortality Rates Down in Recent Years, but Still Higher Than General Population, Study Reports

News

Although mortality rates associated with inflammatory bowel disease (IBD) have declined substantially over recent years, patients diagnosed with IBD as adults still have a higher risk of death than ... Read more

April 26, 2019April 26, 2019

New National Surveys on Medicinal Cannabis Use for IBD Symptoms Launched in Australia

News

Two new national surveys on the use of cannabis for the treatment of patients with inflammatory bowel disease (IBD) have been launched in Australia. The anonymous surveys — one ... Read more

April 5, 2019April 5, 2019

EMA Advances Under-the-skin Injection of Entyvio for Crohn’s and Ulcerative Colitis

News

The European Medicines Agency (EMA) has accepted a Marketing Authorization Line Extension Application for a new subcutaneous (under-the-skin) form of Entyvio (vedolizumab). Entyvio is a biologic agent developed by ... Read more

April 3, 2019April 3, 2019

UK’s NICE Publishes Briefing Supporting PredictImmune Tool for Estimating IBD Flare-up Likelihood

News

The National Institute for Health and Care Excellence (NICE) supports the use of PredictImmune‘s newly launched prognostic tool, PredictSURE IBD, for estimating the likelihoood of disease flare-ups in patients ... Read more

March 27, 2019March 27, 2019

Underweight IBD Patients are More Susceptible to Fatty Liver Disease, Study Suggests

News

Underweight patients with inflammatory bowel disease may be more susceptible to developing non-alcoholic fatty liver disease than those with normal weight, according to a study. The study, “Non-alcoholic fatty ... Read more

March 18, 2019March 18, 2019

Program to Examine Gut Microbiota’s Role in Predicting Response to Therapies

News

uBiome launched a research collaboration program with clinicians from the University of Louisville in Kentucky to investigate the usefulness of the gut microbiome to predict the clinical response of ... Read more

February 18, 2019February 18, 2019

Humira Reduces Early Ulcerative Colitis Features, Trial Analysis Shows

News

AbbVie‘s Humira (adalimumab) reduces early tissue inflammation, rectal bleeding, and stool frequency in patients with ulcerative colitis, according to a post-hoc analysis of two Phase 3 trials. Findings were published ... Read more